A 3.7% revenue miss. That is what it took to wipe out roughly $67 billion in market value and hand IBM its worst single trading day on record.
Let that sink in for a second.
What actually happened
On July 14, IBM CEO Arvind Krishna did something unusual: he released a preliminary earnings letter eight days before the company’s scheduled July 22 conference call. The numbers — Q2 revenue of $17.2 billion (vs. $17.86 billion expected) and operating EPS of $2.93 (vs. about $3.02 expected) — were not catastrophic on their face. Software grew 5%. Consulting held flat. Infrastructure slid 7%.
But the stock closed down 25.21% at $217.07.
The reaction reflects something deeper than the numbers.
Krishna told investors that enterprise clients in the final weeks of June shifted their quarterly capital spending toward servers, storage, and memory purchases — securing supply-constrained infrastructure ahead of expected price increases — at the expense of IBM’s software and consulting budgets. Transaction processing demand softened. Large deal closings slipped. The mainframe infrastructure cycle, which Krishna said had been the strongest start to a mainframe program in company history, also wrapped sharply.
What the market is actually pricing is not a bad quarter. It is the possibility that the budget rotation is structural, not a timing blip.
Analyst Targets (post-warning)
- BofA Securities: Buy, target cut to $280 from $330
- Evercore ISI: Outperform, target $310 (reiterated)
- HSBC: Reduce, target $191
- Oppenheimer: Downgraded to Perform from Outperform
The bigger question nobody is saying out loud
IBM is not alone here. Software and consulting names sold off hard on the open — Microsoft briefly fell around 3%, ServiceNow dropped about 8%, the IGV software ETF dropped 4% before recovering. By midday, most had clawed back. IBM had not.
That divergence tells you something. The market read IBM’s warning as an IBM-specific execution story, not a sector-wide collapse in IT spending. But Krishna’s framing deserves scrutiny: if enterprise clients are actively prioritizing AI hardware over software at the margin, that has read-through to Accenture, Cognizant, and every other IT services name carrying elevated multiples on the premise that AI accelerates enterprise software budgets.
Slight tangent, but it matters: IBM had been trading near $290 before the warning. When a company carrying a premium expectation grows revenue only 1% and then has to pre-warn ahead of the quarter, investors don’t just adjust the quarter. They compress the multiple across the entire forward earnings stream. That is how a modest miss becomes a roughly $67 billion wipeout.
Bull / Base / Bear
Bull: The July 22 full earnings call reveals that the late-June capex shift was purely a timing issue. Deals that slipped close in Q3. Software growth reaccelerates. Full-year guidance is maintained. The stock bounces toward $260-280 on confirmation.
Base: IBM provides partial clarity on July 22 but trims full-year software growth expectations. The stock stabilizes in the $215-240 range as investors wait for Q3 evidence.
Bear: Q3 guidance cuts confirm the capex shift is structural. Consulting stays flat. Software growth decelerates further. The $191 HSBC target becomes the conversation, not the outlier.
Technical context
IBM closed at $217.07 on July 14, near its 52-week low of $212.34. There is not much structural support below current levels. The stock had gained 21% over the prior three months before the warning, which means a lot of momentum buyers are now underwater and may not absorb further selling cleanly.
What to watch on July 22
The single most important data point is whether IBM maintains or cuts full-year guidance. If guidance holds, the timing argument survives. If it gets cut — or if management declines to reaffirm — the market will treat this as a reset of IBM’s entire growth story, not a one-quarter anomaly. Watch consulting revenue closely too: if that segment also softens, the read-through to the broader IT services sector gets louder.
The part people skip in stories like this: IBM has a multi-decade dividend-increase streak, roughly $67.5 billion in annual revenue (most recently reported for 2025), and meaningful positions in quantum computing and AI infrastructure consulting. None of that evaporated on July 14. What evaporated was the premium the market was paying for a software-led acceleration that may take longer to materialize than investors had priced in.
Whether you think $217 is a disaster or an opportunity depends almost entirely on one question: was this a timing issue or a trend? We won’t know the answer until July 22 at 5 p.m. ET.
For informational purposes only.
